CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...
Phase 2
Cleveland, Ohio, United States and 83 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Cleveland, Ohio, United States and 205 other locations
This is a phase 3 study to evaluate zimberelimab (AB122) combined with domvanalimab (AB154) compared to pembrolizumab in front-line, PD-L1-high, loca...
Phase 3
Cleveland, Ohio, United States and 170 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
Cleveland, Ohio, United States and 126 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Cleveland, Ohio, United States and 122 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Cleveland, Ohio, United States and 227 other locations
The research study is testing the investigational drug necitumumab (IMC-11F8) in the treatment of advanced non-small cell ...
Phase 3
Akron, Ohio, United States and 181 other locations
and pharmacokinetics (PK) of BBO-8520, a KRAS G12C (ON) inhibitor, single agent and in combination with pembrolizumab in patients with advanced non...
Phase 1
Cleveland, Ohio, United States and 3 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Cleveland, Ohio, United States and 252 other locations
, early-stage non-small cell lung cancer....
Phase 2
Cleveland, Ohio, United States and 94 other locations
Clinical trials
Research sites
Resources
Legal